Clinical Trial Update: Efficacy of Single Injection Femoral Nerve Block With Liposomal Bupivacaine for Total Knee Arthroplasty [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a single-injection femoral nerve block with liposomal bupivacaine for total knee arthroplasty has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of Knee

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: St. Luke's-Roosevelt Hospital Center | Conditions: Total Knee Arthroplasty | Phase 4 | Status: WITHDRAWN